These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25338552)

  • 21. β-cell replenishment: Possible curative approaches for diabetes mellitus.
    Rathwa N; Patel R; Palit SP; Parmar N; Rana S; Ansari MI; Ramachandran AV; Begum R
    Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):1870-1881. PubMed ID: 32994121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of IL-2 in β cells by AAV8 gene transfer in pre-diabetic NOD mice prevents diabetes through activation of FoxP3-positive regulatory T cells.
    Flores RR; Zhou L; Robbins PD
    Gene Ther; 2014 Aug; 21(8):715-22. PubMed ID: 24849041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
    Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R
    Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agaricus bisporus lectins mediates islet β-cell proliferation through regulation of cell cycle proteins.
    Wang Y; Liu Y; Wang H; Li C; Qi P; Bao J
    Exp Biol Med (Maywood); 2012 Mar; 237(3):287-96. PubMed ID: 22393165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. β Cells that Resist Immunological Attack Develop during Progression of Autoimmune Diabetes in NOD Mice.
    Rui J; Deng S; Arazi A; Perdigoto AL; Liu Z; Herold KC
    Cell Metab; 2017 Mar; 25(3):727-738. PubMed ID: 28190773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
    Fändrich F; Ungefroren H
    Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancing pancreatic Beta-cell regeneration in vivo with pioglitazone and alogliptin.
    Yin H; Park SY; Wang XJ; Misawa R; Grossman EJ; Tao J; Zhong R; Witkowski P; Bell GI; Chong AS
    PLoS One; 2013; 8(6):e65777. PubMed ID: 23762423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes.
    Marzo N; Mora C; Fabregat ME; Martín J; Usac EF; Franco C; Barbacid M; Gomis R
    Diabetologia; 2004 Apr; 47(4):686-94. PubMed ID: 15298346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody Response to Serpin B13 Induces Adaptive Changes in Mouse Pancreatic Islets and Slows Down the Decline in the Residual Beta Cell Function in Children with Recent Onset of Type 1 Diabetes Mellitus.
    Kryvalap Y; Lo CW; Manuylova E; Baldzizhar R; Jospe N; Czyzyk J
    J Biol Chem; 2016 Jan; 291(1):266-78. PubMed ID: 26578518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta Cell Mass Restoration in Alloxan-Diabetic Mice Treated with EGF and Gastrin.
    Song I; Patel O; Himpe E; Muller CJ; Bouwens L
    PLoS One; 2015; 10(10):e0140148. PubMed ID: 26452142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
    Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
    Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of beta-cell regeneration by islet transplantation after partial pancreatectomy in mice.
    Jung HS; Ahn YR; Oh SH; Kim YS; No H; Lee MK; Kim KW
    Transplantation; 2009 Aug; 88(3):354-9. PubMed ID: 19667937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo genetic engineering of murine pancreatic beta cells mediated by single-stranded adeno-associated viral vectors of serotypes 6, 8 and 9.
    Jimenez V; Ayuso E; Mallol C; Agudo J; Casellas A; Obach M; Muñoz S; Salavert A; Bosch F
    Diabetologia; 2011 May; 54(5):1075-86. PubMed ID: 21311856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.
    Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B
    J Immunol; 2010 Nov; 185(9):5120-9. PubMed ID: 20876350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic cell mass from autoimmune destruction in the nonobese diabetic mouse model.
    Marzo N; Ortega S; Stratmann T; García A; Ríos M; Giménez A; Gomis R; Mora C
    J Immunol; 2008 Jan; 180(2):1189-98. PubMed ID: 18178859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Islet remodeling in female mice with spontaneous autoimmune and streptozotocin-induced diabetes.
    Plesner A; Ten Holder JT; Verchere CB
    PLoS One; 2014; 9(8):e102843. PubMed ID: 25101835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-producing intestinal K cells protect nonobese diabetic mice from autoimmune diabetes.
    Mojibian M; Lam AW; Fujita Y; Asadi A; Grassl GA; Dickie P; Tan R; Cheung AT; Kieffer TJ
    Gastroenterology; 2014 Jul; 147(1):162-171.e6. PubMed ID: 24662331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes.
    Marré ML; Profozich JL; Coneybeer JT; Geng X; Bertera S; Ford MJ; Trucco M; Piganelli JD
    J Autoimmun; 2016 Aug; 72():33-46. PubMed ID: 27173406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robo4-mediated pancreatic endothelial integrity decreases inflammation and islet destruction in autoimmune diabetes.
    Troullinaki M; Chen LS; Witt A; Pyrina I; Phieler J; Kourtzelis I; Chmelar J; Sprott D; Gercken B; Koutsilieris M; Chavakis T; Chatzigeorgiou A
    FASEB J; 2020 Feb; 34(2):3336-3346. PubMed ID: 31916652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. β-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection.
    El Khatib MM; Sakuma T; Tonne JM; Mohamed MS; Holditch SJ; Lu B; Kudva YC; Ikeda Y
    Gene Ther; 2015 May; 22(5):430-8. PubMed ID: 25786871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.